Guidelines for evaluating end-stage lung disease are not fully standardized, so decisions to list patients for lung transplant are made at clinicians’ discretion. Because of disparities in medical care, it is critically important to understand factors that may affect the likelihood of listing. To gain insights, Jacquelyn B. Kercheval, MD, and colleagues examined the characteristics and outcomes of patients who are assessed but do not make the list.

Investigators in the single-center retrospective study used electronic health records to describe patients who had an in-person assessment for lung transplant. They extracted data on exclusion from the wait list, time to listing, and death, and then used multivariate competing-risk models to identify independent risk factors for listing.

The results showed that between January 1, 2020, and September 2, 2025, 497 patients were assessed for lung transplant, and 289 (58%) were placed on the wait list. Patients who were not listed were predominantly non-Hispanic White (n=215, 77%) and male (n=190, 66%). About half had restrictive lung disease (n=146, 51%).

After adjustment, patients had a 55% lower likelihood of being listed if they were aged 70 years or older compared with those aged 18 to 40 years, 38% less likely if they had a history of heart failure, and 37% less likely if male (P<0.05 for all). Importantly, those not listed also had a significantly higher risk for death following evaluation.

In summary, the authors wrote, “This study suggests that at our center, older male patients with a history of heart failure are less likely to be listed, and mortality is higher for patients who do not get listed.” They also recommended further research to assess the characteristics of referred patients to better understand practices in evaluating lung transplant candidacy.